CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-24 | Venker Eric President & COO | Sale 10b5-1 | −434,478 | $10.82 | $4.7M | 1,127,290 |
| 2025-03-24 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −602,311 | 9,923,923 | ||
| 2025-03-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,945 | $10.97 | $120K | 874,979 |
| 2025-03-20 | Venker Eric President & COO | Option exercise 10b5-1 | +400,000 | $3.85 | $1.5M | 1,274,979 |
| 2025-03-20 | Venker Eric President & COO | Sale 10b5-1 | −315,522 | $11.06 | $3.5M | 959,457 |
| 2025-03-20 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −400,000 | 10,526,234 | ||
| 2025-03-20 | Humes Jennifer Chief Accounting Officer | Grant or award | +112,255 | 112,255 | ||
| 2025-03-20 | Humes Jennifer Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +115,108 | 115,108 | ||
| 2025-03-20 | Pulik Richard CFO | Shares withheld for taxes | −1,504 | $10.97 | $16K | 267,541 |
| 2025-03-20 | Gline Matthew CEO | Shares withheld for taxes | −10,945 | $10.97 | $120K | 17,305,656 |
| 2025-02-28 | Pulik Richard CFO | Shares withheld for taxes | −1,635 | $10.74 | $18K | 269,045 |
| 2025-02-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes | −958 | $10.72 | $10K | 162,306 |
| 2025-02-20 | Gline Matthew CEO | Shares withheld for taxes | −10,945 | $10.72 | $117K | 17,316,601 |
| 2025-02-20 | Venker Eric President & COO | Option exercise | +100,000 | $3.85 | $385K | 996,869 |
| 2025-02-20 | Venker Eric President & COO | Sale | −100,000 | $10.65 | $1.1M | 896,869 |
| 2025-02-20 | Venker Eric President & COO | Shares withheld for taxes | −10,945 | $10.72 | $117K | 885,924 |
| 2025-02-20 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) | −100,000 | 10,926,234 | ||
| 2025-02-13 | Kumar Rakhi Chief Accounting Officer | Option exercise | +187,500 | $3.85 | $722K | 390,764 |
| 2025-02-13 | Kumar Rakhi Chief Accounting Officer | Sale | −227,500 | $10.43 | $2.4M | 163,264 |
| 2025-02-13 | Kumar Rakhi Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) | −187,500 | 312,500 |
Page 24 of 29 · 570 trades